NCT05283005

Brief Summary

Reconstruction of Alveolar Cleft Using Double Iliac Corticocancellous Blocks in comparison with the gold standard technique ( cancellous bone ) both from anterior iliac crest.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 28, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 16, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 16, 2022

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

February 16, 2022

Last Update Submit

March 7, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Measuring graft height in millimeters

    CBCT scan analysis for measuring mean graft height in millimeters of every graft of both groups of patients immediately after surgery and compare it with CBCT scan analysis for measuring mean graft height in millimeters after 9 months of every graft for assessment of grafts height stability of both groups over 9 months.

    9 months

  • Measuring graft width in millimeters

    CBCT scan analysis for measuring mean graft width in millimeters of every graft of both groups of patients immediately after surgery and compare it with CBCT scan analysis for measuring mean graft width in millimeters after 9 months of every graft for assessment of grafts width stability of both groups over 9 months.

    9 months

Secondary Outcomes (1)

  • Measuring graft volume in cubic millimeter

    9 months

Study Arms (2)

alveolar cleft patients will be treated by conventional technique

ACTIVE COMPARATOR

Reconstruction of alveolar cleft by autogenous cancellous bone from the anterior iliac crest (gold standard technique).

Procedure: Grafting of the alveolar cleft

alveolar cleft patients will be treated by double cortex technique

EXPERIMENTAL

Reconstruction of alveolar cleft by autogenous double iliac cortico-cancellous bone blocks from the anterior iliac crest.

Procedure: Grafting of the alveolar cleft

Interventions

alveolar cleft grafting using either the conventional technique or the double cortex technique

alveolar cleft patients will be treated by conventional techniquealveolar cleft patients will be treated by double cortex technique

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Patients with complete maxillary alveolar cleft either unilateral or bilateral at the age of mixed dentition (between 7 and 13 years old).
  • repaired cleft lip.
  • Patients with cleft lip and palate who have not undergone alveolar grafting procedure.
  • Patients with unerupted maxillary permanent canine in the cleft region.
  • Patients with medical history that did not hinder surgical intervention and have adequate proper oral hygiene.
  • Both genders males and females will be included

You may not qualify if:

  • General contraindications to surgical intervention of the area. Patients with ill repaired cleft lip that will hinder the appropriate reconstruction of the alveolar cleft.
  • Patients with associated syndrome.
  • Patients requiring concomitant Orthognathic surgical procedure.
  • Subjected to irradiation in the head and neck area less than 1 year before surgery.
  • Untreated periodontitis.
  • Poor oral hygiene.
  • Uncontrolled diabetes.
  • Immunosuppressed or immunocompromised.
  • Treated or under treatment with intravenous amino-bisphosphonates.
  • Active infection or severe inflammation in the area intended for graft placement.
  • Patients participating in other studies, if the present protocol could not be properly followed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry, Cairo university

Cairo, Egypt

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 16, 2022

First Posted

March 16, 2022

Study Start

December 28, 2021

Primary Completion

December 29, 2022

Study Completion

December 31, 2022

Last Updated

March 16, 2022

Record last verified: 2022-03

Locations